Showing results (1-10 of 251) with videos related to
Sort By:
Pageof 26
Cell|September 9, 2006
Mind the GAP: Wnt steps onto the mTORC1 trainAndrew Y Choo, Philippe P Roux, John BlenisProceedings of the National Academy of Sciences of the United States of America|October 29, 2008
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translationAndrew Y Choo, Sang-Oh Yoon, Sang Gyun Kim, et al.Cell Cycle (Georgetown, Tex.)|February 7, 2009
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapyAndrew Y Choo, John BlenisCancer Cell|February 14, 2006
TORgeting oncogene addiction for cancer therapyAndrew Y Choo, John BlenisMicrobiology and Molecular Biology Reviews : MMBR|June 10, 2004
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functionsPhilippe P Roux, John BlenisMolecular Cell|November 25, 2010
ATM: Promoter of metabolic "cost" reduction and "savings" usage during hypoxia through mTORC1 regulationSang Gyun Kim, Andrew Y Choo, John BlenisMolecular and Cellular Biology|July 2, 2003
Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activityPhilippe P Roux, Stephanie A Richards, John BlenisFrontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The RSK factors of activating the Ras/MAPK signaling cascadeAudrey Carriere, Hind Ray, John Blenis, et al.Current Biology : CB|October 11, 2005
The tumor suppressor DAP kinase is a target of RSK-mediated survival signalingRana Anjum, Philippe P Roux, Bryan A Ballif, et al.Proceedings of the National Academy of Sciences of the United States of America|September 3, 2004
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinasePhilippe P Roux, Bryan A Ballif, Rana Anjum, et al.Pageof 26